In an animal model of Parkinson’s disease, selective activation of GPER reduced lipopolysaccharide-induced microglial reactivity, protected nigral dopaminergic neurons, and prevented impairment of motor neurons [250,251]. The gene discussed is GPER1; the disease is Parkinson disease.